Details
Stereochemistry | ACHIRAL |
Molecular Formula | C10H12O2 |
Molecular Weight | 164.2011 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(CC=C)=CC=C1O
InChI
InChIKey=RRAFCDWBNXTKKO-UHFFFAOYSA-N
InChI=1S/C10H12O2/c1-3-4-8-5-6-9(11)10(7-8)12-2/h3,5-7,11H,1,4H2,2H3
Molecular Formula | C10H12O2 |
Molecular Weight | 164.2011 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.marinwater.org/DocumentCenter/View/253Curator's Comment: description was created based on several sources, including:
https://www.drugs.com/otc/470846/eugenol-toothache-medication.html | http://www.indepthinfo.com/nutrition/eugenol.htm
Sources: https://www.marinwater.org/DocumentCenter/View/253
Curator's Comment: description was created based on several sources, including:
https://www.drugs.com/otc/470846/eugenol-toothache-medication.html | http://www.indepthinfo.com/nutrition/eugenol.htm
Eugenol is sometimes called clove oil because it is the active element in cloves. It causes the aromatic smell typical of cloves and because of this property is often found in perfumes. Eugenol’s properties make it a good local antiseptic and analgesic. It is used in dentist offices to make zinc-oxide eugenol paste for temporary fillings. Eugenol also demonstrates antifungal and antimicrobial activity, showing efficacy against Candida albicans biofilms, Listeria monocytogenes and Escherichia coli. Eugenol is further described to induce reactive oxygen species (ROS) production and to scavenge ROS, thus demonstrating prooxidant and antioxidant effects. Also, Eugenol is used as a pesticide.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:1903409 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12126794 |
|||
Target ID: CHEMBL4794 Sources: https://www.ncbi.nlm.nih.gov/pubmed/14514756 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | DENTEK EUGENOL Approved UseFor the temporary relief of throbbing, persistent toothache due to cavity. |
PubMed
Title | Date | PubMed |
---|---|---|
In vitro human T cell sensitization to haptens by monocyte-derived dendritic cells. | 2000 Dec |
|
Anethole blocks both early and late cellular responses transduced by tumor necrosis factor: effect on NF-kappaB, AP-1, JNK, MAPKK and apoptosis. | 2000 Jun 8 |
|
In vitro and in vivo activity of eugenol on human herpesvirus. | 2000 Nov |
|
Effects of isoeugenol on oxidative stress pathways in normal and streptozotocin-induced diabetic rats. | 2001 |
|
Evaluation of volatile chemical treatments for lethality to Salmonella on alfalfa seeds and sprouts. | 2001 Apr |
|
Methyleugenol and eugenol variation in Ocimum basilicum cv. Genovese gigante grown in greenhouse and in vitro. | 2001 Apr-Jun |
|
Biotechnological production of vanillin. | 2001 Aug |
|
Oxidation of cinnamyl alcohols and aldehydes by a basic peroxidase from lignifying Zinnia elegans hypocotyls. | 2001 Aug |
|
The effect of various root canal sealers on India ink and different concentrations of methylene blue solutions. | 2001 Dec |
|
Antimicrobial activity of four root canal sealers against endodontic pathogens. | 2001 Dec |
|
Capillary zone electrophoresis of coniferyl alcohol oxidation products. | 2001 Dec |
|
Functional magnetic resonance imaging of odor identification: the effect of aging. | 2001 Dec |
|
Inhibition of malonaldehyde formation from blood plasma oxidation by aroma extracts and aroma components isolated from clove and eucalyptus. | 2001 Dec |
|
Measurement of urinary methoxyphenols and their use for biological monitoring of wood smoke exposure. | 2001 Feb |
|
Evaluation of eugenol allergy in a patch-test population. | 2001 Jan |
|
Inhibitory effects of eugenol and thymol on Penicillium citrinum strains in culture media and cheese. | 2001 Jul 20 |
|
Effects of eugenol on resin bond strengths to root canal dentin. | 2001 Jun |
|
Formaldehyde release from ground root canal sealer in vitro. | 2001 Jun |
|
Insecticidal activity of essential oils: octopaminergic sites of action. | 2001 Nov |
|
Influence of eugenol-containing temporary restorations on bond strength of composite to dentin. | 2001 Nov-Dec |
|
Fragrance chemicals in domestic and occupational products. | 2001 Oct |
|
Characterization of the eugenol hydroxylase genes (ehyA/ehyB) from the new eugenol-degrading Pseudomonas sp. strain OPS1. | 2001 Sep |
|
Use of a B cell marker (B220) to discriminate between allergens and irritants in the local lymph node assay. | 2002 Aug |
|
The effects of eugenol and epoxy-resin on the strength of a hybrid composite resin. | 2002 Feb |
|
Multicentre study of fragrance allergy in Hungary. Immediate and late type reactions. | 2002 Jun |
|
Character impact odorants of the apple cultivars Elstar and Cox Orange. | 2002 Jun |
|
Effect of dowel space preparation and composite cement thickness on retention of a prefabricated dowel. | 2002 Mar |
|
Aspergillus flavus dose-response curves to selected natural and synthetic antimicrobials. | 2002 Mar |
|
Inhibition of intestinal motility by methanol extracts of Hibiscus sabdariffa L. (Malvaceae) in rats. | 2002 May |
|
Phenotypic alterations and IL-1beta production in CD34(+) progenitor- and monocyte-derived dendritic cells after exposure to allergens: a comparative analysis. | 2002 May |
|
Enzymatic synthesis of aroma compound xylosides using transfer reaction by Trichoderma longibrachiatum xylanase. | 2002 Sep 25 |
Patents
Sample Use Guides
Rinse tooth with water to remove any food particles from the cavity. Moisten a cotton pellet with 1 or 2 drops of medication and using the tweezer, place in the cavity for approximately 1 minute. Avoid touching tissues other than the tooth cavity . Apply the dose not more than four times daily.
Route of Administration:
Dental
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17356790
Eugenol displayed in vitro activity against C. albicans cells within biofilms, when MIC(50) for sessile cells was 500 mg/L. C. albicans adherent cell populations (after 0, 1, 2 and 4 h of adherence) were treated with various concentrations of eugenol (0, 20, 200 and 2,000 mg/L). The extent of subsequent biofilm formation were then assessed with the tetrazolium salt reduction assay. Effect of eugenol on morphogenesis of C. albicans cells was observed by scanning electron microscopy (SEM). The results indicated that the effect of eugenol on adherent cells and subsequent biofilm formation was dependent on the initial adherence time and the concentration of this compound, and that eugenol can inhibit filamentous growth of C. albicans cells.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:00:36 GMT 2023
by
admin
on
Fri Dec 15 15:00:36 GMT 2023
|
Record UNII |
3T8H1794QW
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EC SCIENTIFIC COMMITTEE ON CONSUMER SAFETY OPINION |
SCCS/1459/11
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
||
|
DSLD |
2902 (Number of products:13)
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
||
|
NCI_THESAURUS |
C245
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
||
|
JECFA EVALUATION |
EUGENOL
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
||
|
NDF-RT |
N0000185508
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
||
|
EPA PESTICIDE CODE |
102701
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
eugenol
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
PRIMARY | |||
|
100000078677
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
PRIMARY | |||
|
DTXSID9020617
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
PRIMARY | |||
|
4186
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
PRIMARY | RxNorm | ||
|
N0000175629
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
PRIMARY | Increased Histamine Release [PE] | ||
|
4917
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
PRIMARY | |||
|
97-53-0
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
PRIMARY | |||
|
210
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
PRIMARY | |||
|
DB09086
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
PRIMARY | |||
|
202-589-1
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
PRIMARY | |||
|
N0000184306
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
PRIMARY | Cell-mediated Immunity [PE] | ||
|
3T8H1794QW
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
PRIMARY | |||
|
3314
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
PRIMARY | |||
|
209525
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
PRIMARY | |||
|
D005054
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
PRIMARY | |||
|
4648
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
PRIMARY | |||
|
1520
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
PRIMARY | |||
|
1268965
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
PRIMARY | |||
|
8895
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
PRIMARY | |||
|
3T8H1794QW
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
PRIMARY | |||
|
SUB13776MIG
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
PRIMARY | |||
|
CHEMBL42710
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
PRIMARY | |||
|
m5210
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
PRIMARY | Merck Index | ||
|
C75095
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
PRIMARY | |||
|
N0000171131
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
PRIMARY | Allergens [Chemical/Ingredient] | ||
|
EUGENOL
Created by
admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
ASSAY (GC)
|
||
|
PARENT -> CONSTITUENT MAY BE PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT MAY BE PRESENT |
ASSAY (GC)
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
A cinnamon leaf oil of Chinese origin, Cinnamomun japonicum Sieb., contains a high concentration of safrole (60%) and only about 3% eugenol.
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
USP
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
ASSAY (GC)
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
USP
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
In view of the toxic properties documented for the oil and associated with beta-asarone , it has been recommended that only beta-asarone-free calamus root should be used in phytotherapy.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |